Research Articles | Page 3 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Mar 2021 The New England Journal of Medicine paroxysmal nocturnal hemoglobinuria (PNH)
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes Jan 2020 The New England Journal of Medicine myelodysplastic syndromes (MDS)
Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial Jun 2019 The Lancet Haematology myelodysplastic syndromes (MDS)
Paroxysmal nocturnal hemoglobinuria without GPI-anchor deficiency Oct 2019 The Journal of Clinical Investigation paroxysmal nocturnal hemoglobinuria (PNH)
Defining the Boundary Between Myelodysplastic Syndromes and Myeloproliferative Neoplasms Jul 2019 Surgical Pathology Clinic myelodysplastic syndromes (MDS)
Impaired proliferative potential of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway Mar 2014 Stem Cells Dev myelodysplastic syndromes (MDS)
The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemia Jan 2021 Seminars in Hematology acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
Lenalidomide: Myelodysplastic syndromes with del(5q) and beyond Sep 2017 Semin Hematol myelodysplastic syndromes (MDS)
Optimizing the use of hypomethylating agents in myelodysplastic syndromes: Selecting the candidate, predicting the response, and enhancing the activity Sep 2017 Semin Hematol myelodysplastic syndromes (MDS)
Increasing the effectiveness of hematopoiesis in myelodysplastic syndromes: erythropoiesis-stimulating agents and transforming growth factor-β superfamily inhibitors Sep 2017 Semin Hematol myelodysplastic syndromes (MDS)
Share with addtoany.com.